Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

DIAMOND Shines Bright on Patiromer for Curbing Hyperkalemia in HFrEF

News Conference News ACC 2022

DIAMOND Shines Bright on Patiromer for Curbing Hyperkalemia in HFrEF

April 08, 2022

In Vaccine Era, Deaths Drop Sharply in STEMI Patients With COVID-19

News Conference News ACC 2022

In Vaccine Era, Deaths Drop Sharply in STEMI Patients With COVID-19

April 04, 2022

Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS

News Conference News ACC 2022

Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS

Michael O'Riordan

March 25, 2022

Wide Variation in TAVI Readmission Rates Among US Hospitals

News Conference News ACC 2021

Wide Variation in TAVI Readmission Rates Among US Hospitals

May 07, 2021

New Patient-Focused TAVR Quality Score Rolling Out to US Hospitals

News Conference News ACC 2020

New Patient-Focused TAVR Quality Score Rolling Out to US Hospitals

Michael O'Riordan

April 06, 2020

Lower Risk of Death With Conscious Sedation in TAVR: TVT Registry

News Conference News ACC 2020

Lower Risk of Death With Conscious Sedation in TAVR: TVT Registry

Michael O'Riordan

March 19, 2020

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

News Conference News ACC 2019

SAFARI Surprise: No Survival or Bleeding Advantage With Radial Over Femoral Access in STEMI

Michael O'Riordan

March 18, 2019

Off Script: As the Quantification of Cath Lab Quality Gets an Upgrade, Frustrations Abound

News Opinion Off Script ACC 2019

Off Script: As the Quantification of Cath Lab Quality Gets an Upgrade, Frustrations Abound

March 17, 2019

Perioperative MIs Bring Too Many Patients Back to the Hospital After Noncardiac Surgery

News Conference News ACC 2018

Perioperative MIs Bring Too Many Patients Back to the Hospital After Noncardiac Surgery

Yael L. Maxwell

March 10, 2018

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.